Hyper Corporation Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for Alzheimer's disease (AD) and neuropathic pain, as well as AD diagnostics. Its pipeline includes TRPV1 antagonist and agonist candidates for neuropathic pain, and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD. The company also wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, and provides online content. In addition, it manufactures and supplies frozen and room-temperature convenience foods under brands such as Memories of Elementary School Tteokbokki, Newtro, and K-TOWN. Formerly known as Medifron DBT Co., Ltd., it changed its name to Hyper Corporation Inc. in March 2024. Founded in 1997, it is headquartered in Seoul, South Korea.